CeriBell (FRA:W3H) Interest Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:W3H CeriBell Inc FRA:W3H
20 GF Score
Price €20.50
! 4 Warning Signs
View Full Analysis

What is CeriBell Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

FRA:W3H
20GF Score
CeriBell Inc FRA:W3H
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CeriBell Business Description

Other Exchanges CBLL:USA
Address 360 N. Pastoria Avenue, Sunnyvale, CA, USA, 94085
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.
20GF Score

Get the complete analysis for FRA:W3H

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€20.50
Price